Filing Details
- Accession Number:
- 0001209191-22-062125
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-20 13:29:53
- Reporting Period:
- 2022-12-16
- Accepted Time:
- 2022-12-20 13:29:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1160308 | Savara Inc | SVRA | Pharmaceutical Preparations (2834) | 841318182 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1283292 | A David Ramsay | 6836 Bee Cave Road Building Iii, Suite 201 Austin TX 78746 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-12-16 | 341 | $1.50 | 1,946,593 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-12-19 | 40,719 | $1.49 | 1,987,312 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-12-20 | 13,830 | $1.50 | 2,001,142 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The price is a weighted average purchase price. The purchase prices ranged from $1.47 to $1.52. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
- The price is a weighted average purchase price. The purchase prices ranged from $1.485 to $1.53. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
Billionaire Hedge Funds
